Ceapro Inc V.CZO

Hope for the Best, this is a viable path forward

[Ciao]

Hopeforthebest, to reply on this comment,

" it arguably values CZO's at a target price between C$1.25-C$2.20 per CZO share. That would obviously take PGX into account "

At the current market cap, PGX is trading for cash and 1/3 Price/Sales, and ZERO for PGX.

It's what management can do with the assets (we are reminded of the value of PGX in multiple NR and from the subject matter experts), and Gilles is the common denominator for AEZS / CZO management and has proven himself to be incapable.

This is a sham takeover of CZO at a fire sale liquidation valuation instead of a premium. Thus the share price has dropped to new lows instead of rising.

Let's consider this:

1) Q4 sales recover as KENVUE needs to re-stock, as Gilles said, SYMRISE's product is not a replacement for CEAPRO's AV so they need to re-order from CEAPRO (unless of course AVENNO sales have taken a massive hit)

2) shareholders vote no to the sham merger

3) the share price rapidly recovers once the sham merger is given an convincing NO (heck it is trading at less than liquidation value, and the phase 1/2a results should be out in 8 months)

4)  large shareholder groups call for his Gilles removal and he is kicked off the board in June

5) the board realizes that shareholders are threatening to sue the board for not behaving in the best interests (fudiciary resp) of shareholders (recommending the sham merger, not responding to and removing Gilles as the CEO) and hire a capable and motivated CEO

6) with about $10M in cash, an entrepreneur type, energetic, Alpha male CEO starts to make relationships with commercial interests, retail investors, fund managers over the next 1 - 2 years and the stock hits 52 week and 7 year old highs

OATS, your group can make this happen, we need your NO votes.

[prophetoffactz]

" it arguably values CZO's at a target price between C$1.25-C$2.20 per CZO share. That would obviously take PGX into account " When AEZS announces its diagnostic deal given that CZO has been valued the same as AEZS in the merger it will help the market see the value of CZO by implication. With AEZS's clinical trial expected to be fully enrolled by the end of 2023 a

[tigerpro]

Is it legal that Gilles doesn't communicate with shareholders but frequently provides insider information to Prop? Is it legal that Gilles pays Prop to spread wrong and misleading information to shareholders? Can shareholders sue both of them in the future?

[Ciao]

Hard to prove if material information is being selectively disclosed. Easier to use the Board for neglecting fiduciary responsibility. This sham merger could be easier to prove, attempt to merge a low risk company with a high risk cash burning biotech but most of all not replacing Gilles given his record of poor performance over the decade. How can he sit collecting an annual 500K salary for